Financials

  • Market Capitalization 1.64 B
  • Employee 367
  • Founded 2016
  • CEO Marianne De Backer
  • Website www.vir.bio
  • Headquarter Delaware, United States
  • FIGI BBG00H2QQ8T5
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-1.91
Fiyat/satışlar oranı
12.18

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
2124
IMCR
Immunocore Holdings plc - American Depositary Shares
32.49 USD+1.69%+1.15%+12.19%-2.96%1.65 B USD
2127
MRVI
Maravai LifeSciences Holdings, Inc. - Class A common stock
6.36 USD+4.43%+7.80%+26.69%+139.10%1.64 B USD
2131
INVA
Innoviva, Inc. - Common Stock
22.21 USD-0.13%+0.45%-2.24%+24.64%1.64 B USD
2146
ABSI
Absci Corporation - Common Stock
10.21 USD-3.68%-14.06%+38.72%+283.83%1.59 B USD

Haberler